Mckinley Capital Management Raised Enzo Biochem (ENZ) Stake By $1.42 Million; Bbva Compass Bancshares Raised By $390,345 Its Regeneron Pharmaceuticals (REGN) Stake

November 8, 2017 - By Nellie Frank

Mckinley Capital Management Inc increased Enzo Biochem Inc (ENZ) stake by 39.8% reported in 2017Q2 SEC filing. Mckinley Capital Management Inc acquired 129,538 shares as Enzo Biochem Inc (ENZ)’s stock rose 31.87%. The Mckinley Capital Management Inc holds 455,042 shares with $5.02 million value, up from 325,504 last quarter. Enzo Biochem Inc now has $458.96 million valuation. The stock decreased 0.80% or $0.08 on November 8, reaching $9.86. About 100,744 shares traded. Enzo Biochem, Inc. (NYSE:ENZ) has risen 44.32% since November 8, 2016 and is uptrending. It has outperformed by 27.62% the S&P500.

Bbva Compass Bancshares Inc increased Regeneron Pharmaceuticals (REGN) stake by 5.96% reported in 2017Q2 SEC filing. Bbva Compass Bancshares Inc acquired 795 shares as Regeneron Pharmaceuticals (REGN)’s stock rose 21.24%. The Bbva Compass Bancshares Inc holds 14,137 shares with $6.94 million value, up from 13,342 last quarter. Regeneron Pharmaceuticals now has $44.49B valuation. The stock increased 2.67% or $10.78 during the last trading session, reaching $415.17. About 1.07 million shares traded or 27.54% up from the average. Regeneron Pharmaceuticals Inc (NASDAQ:REGN) has risen 17.40% since November 8, 2016 and is uptrending. It has outperformed by 0.70% the S&P500.

Bbva Compass Bancshares Inc decreased Cisco Systems Incorporated (NASDAQ:CSCO) stake by 47,275 shares to 577,881 valued at $18.09 million in 2017Q2. It also reduced United Parcel Service Inc (NYSE:UPS) stake by 8,654 shares and now owns 84,935 shares. Ishares Tr S&P 500 Val Etf (IVE) was reduced too.

Since May 12, 2017, it had 1 insider buy, and 6 insider sales for $44.10 million activity. Shares for $4.01M were sold by STAHL NEIL on Wednesday, June 14. BROWN MICHAEL S sold 2,000 shares worth $948,890. On Friday, June 9 the insider GOLDSTEIN JOSEPH L sold $482,550. VAGELOS P ROY also sold $4.26 million worth of Regeneron Pharmaceuticals Inc (NASDAQ:REGN) on Thursday, May 25. 21,147 shares were sold by Terifay Robert J, worth $9.90 million. 136,050 shares were bought by Sanofi, worth $65.06M on Friday, June 2.

Investors sentiment increased to 1.38 in Q2 2017. Its up 0.12, from 1.26 in 2017Q1. It is positive, as 42 investors sold REGN shares while 157 reduced holdings. 84 funds opened positions while 190 raised stakes. 71.53 million shares or 1.38% more from 70.55 million shares in 2017Q1 were reported. Warren Averett Asset Lc holds 431 shares or 0.05% of its portfolio. Stifel Financial owns 75,914 shares or 0.14% of their US portfolio. Princeton Mgmt Incorporated has 2,511 shares for 0.78% of their portfolio. Her Majesty The Queen In Right Of The Province Of Alberta As Represented By Alberta Mgmt Corp has invested 0.18% in Regeneron Pharmaceuticals Inc (NASDAQ:REGN). Westpac Banking has 5,187 shares for 0% of their portfolio. Bartlett & Ltd Company invested in 0% or 55 shares. Parallax Volatility Advisers Ltd Partnership stated it has 0% of its portfolio in Regeneron Pharmaceuticals Inc (NASDAQ:REGN). Wells Fargo Co Mn holds 385,921 shares or 0.06% of its portfolio. Secor Advsr Lp holds 2,673 shares. Welch Forbes Lc holds 0.01% or 599 shares. Prelude Capital Mgmt Ltd Com accumulated 623 shares. Howe & Rusling stated it has 0% of its portfolio in Regeneron Pharmaceuticals Inc (NASDAQ:REGN). Evercore Wealth Mgmt Limited Liability Corporation stated it has 0.03% of its portfolio in Regeneron Pharmaceuticals Inc (NASDAQ:REGN). Valley National Advisers reported 15 shares. Nippon Life Company owns 0.05% invested in Regeneron Pharmaceuticals Inc (NASDAQ:REGN) for 5,030 shares.

Among 29 analysts covering Regeneron Pharmaceuticals Inc. (NASDAQ:REGN), 14 have Buy rating, 1 Sell and 14 Hold. Therefore 48% are positive. Regeneron Pharmaceuticals Inc. had 93 analyst reports since July 28, 2015 according to SRatingsIntel. As per Monday, April 4, the company rating was maintained by Roth Capital. The stock of Regeneron Pharmaceuticals Inc (NASDAQ:REGN) has “Neutral” rating given on Tuesday, February 16 by Chardan Capital Markets. BTIG Research maintained it with “Buy” rating and $54000 target in Friday, June 30 report. On Friday, July 28 the stock rating was maintained by Canaccord Genuity with “Buy”. Chardan Capital Markets maintained Regeneron Pharmaceuticals Inc (NASDAQ:REGN) rating on Friday, January 6. Chardan Capital Markets has “Neutral” rating and $345 target. As per Thursday, August 3, the company rating was maintained by J.P. Morgan. The firm has “Buy” rating given on Wednesday, August 16 by Evercore. The stock has “Neutral” rating by Chardan Capital Markets on Monday, August 31. The stock of Regeneron Pharmaceuticals Inc (NASDAQ:REGN) earned “Market Perform” rating by Wells Fargo on Wednesday, April 20. Credit Suisse downgraded the shares of REGN in report on Friday, July 14 to “Hold” rating.

Mckinley Capital Management Inc decreased Paycom Software Inc (NYSE:PAYC) stake by 6,096 shares to 148,941 valued at $10.19M in 2017Q2. It also reduced Cimarex Energy Co (NYSE:XEC) stake by 3,942 shares and now owns 91,785 shares. Illinois Tool Works Inc. (NYSE:ITW) was reduced too.

Investors sentiment increased to 1.59 in 2017 Q2. Its up 0.30, from 1.29 in 2017Q1. It is positive, as 12 investors sold ENZ shares while 27 reduced holdings. 28 funds opened positions while 34 raised stakes. 25.22 million shares or 2.12% more from 24.70 million shares in 2017Q1 were reported. Florida-based State Board Of Administration Of Florida Retirement System has invested 0% in Enzo Biochem, Inc. (NYSE:ENZ). California State Teachers Retirement Sys holds 72,917 shares or 0% of its portfolio. Neuberger Berman Gp Ltd Liability holds 23,895 shares. Vanguard Grp holds 0% or 1.75M shares. Mckinley Capital Management Limited Company Delaware reported 0.19% in Enzo Biochem, Inc. (NYSE:ENZ). First Light Asset Lc reported 1.49% of its portfolio in Enzo Biochem, Inc. (NYSE:ENZ). Legal General Group Public Limited Co holds 0% in Enzo Biochem, Inc. (NYSE:ENZ) or 10,663 shares. Renaissance Techs Ltd Com invested in 2.07M shares or 0.03% of the stock. Hutchin Hill Cap Lp holds 0.02% of its portfolio in Enzo Biochem, Inc. (NYSE:ENZ) for 43,900 shares. Dimensional Fund Advsr Lp invested in 2.03M shares. Federated Investors Pa accumulated 119,006 shares. Tiaa Cref Inv Mgmt Ltd Co invested in 533,923 shares or 0% of the stock. Connor Clark Lunn Invest Ltd accumulated 20,820 shares or 0% of the stock. Parametric Assoc Limited Liability Company accumulated 46,718 shares. Sei has invested 0% of its portfolio in Enzo Biochem, Inc. (NYSE:ENZ).

Since June 13, 2017, it had 0 buys, and 1 sale for $160,054 activity. $160,054 worth of stock was sold by O’Brien James Michael on Tuesday, June 13.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By1 Nellie Frank




Automatic Stock Updates

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: